Sarah Milner

Sarah Milner is an experienced medical writer and director, currently serving as the Director of Medical Writing at ELIQUENT Life Sciences since August 2024. Sarah has hands-on experience in scientific writing, having held the position of Director of Scientific Writing at PTC Therapeutics, Inc., where regulatory writing for the Sepiapterin PKU product was a key responsibility. In addition, Sarah contributes as a Volunteer Associate Editor at the European Medical Writers Association since March 2023 and mentors sixth-form STEM students through the Pankhurst Appeal Mentoring Programme at Manchester High School for Girls. With a strong background in clinical trial management and regulatory writing from previous roles at Synchrogenix and The Clinical Trial Company Ltd, Sarah's academic qualifications include a PhD in Dermatology from Newcastle University, alongside a BScHons in Biomedical Sciences.